Form 483

SnugZ USA, Inc. Form 483, 2026-05-01

FDA issued a Form 483 to SnugZ USA, Inc. on 2026-05-01 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

SnugZ USA, Inc. · West Jordan, United States · Issued May 1, 2026

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

1 May 2026
21 CFR 211.110(c)

In-process materials characteristics testing

Cited by Shanna N Purdy

1 May 2026
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Shanna N Purdy

1 May 2026
21 CFR 211.130

Procedures are written, and followed

Cited by Shanna N Purdy

1 May 2026
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Shanna N Purdy

1 May 2026
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Shanna N Purdy

Inspected site

SUSnugZ USA, Inc.West Jordan, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(c)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.130Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere